| Comparing clinical characteristics and outcomes of young-onset and late-onset colorectal cancer: an international collaborative study YS Rho, M Gilabert, K Polom, A Aladashvili, K Kopeckova, V Megdanova, ... Clinical colorectal cancer 16 (4), 334-342, 2017 | 59 | 2017 |
| Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer MP Petrova, IS Donev, MA Radanova, MI Eneva, EG Dimitrova, ... Clinical & Experimental Immunology 202 (3), 353-362, 2020 | 37 | 2020 |
| Systemic treatment selection for patients with advanced pancreatic neuroendocrine tumours (PanNETs) VG Megdanova-Chipeva, A Lamarca, A Backen, MG McNamara, ... Cancers 12 (7), 1988, 2020 | 14 | 2020 |
| BABEL working group of the COST Action 18122 (EURO-CHOLANGIO-NET), part of the European Network for the Study of Cholangiocarcinoma. Bridging the equity gap in patient … megdanova-chipeva Lancet Oncol. 23 (5), P568-570, 2020 | 2* | 2020 |
| Lung cancer in Bulgaria‒diagnosis, treatment, and factors affecting survival: Bulgarian Single Institution experience in lung cancer treatment Z Mihaylova, V Megdanova, V Petrova, D Petkova, A Fakirova, M Petrova, ... memo-Magazine of European Medical Oncology 8, 136-143, 2015 | 1 | 2015 |
| Clinical outcomes of adolescent and young adults (AYA) with colorectal cancer (CRC), a multi-institutional retrospective review (MIRR). Y Rho, M Gilabert, N Coleman, M Greally, VG Megdanova, ZM Milanova, ... Journal of Clinical Oncology 33 (15_suppl), e14692-e14692, 2015 | 1 | 2015 |
| 1318P Neutrophil extracellular traps as a potential predictive marker for treatment with pembrolizumab alone or with chemotherapy as a first-line in patients with metastatic … M Petrova, D Parvanov, R Ganeva, D Metodiev, S Bachurska, ... Annals of Oncology 32, S1013, 2021 | | 2021 |
| Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer I Donev, M Petrova, M Radanova, M Eneva, E Dimitrova, G Valchev, ... Authorea Preprints, 2020 | | 2020 |
| 338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer YS Rho, M Gilabert, K Polom, A Aladashvili, K Kubackova, V Megdanova, ... European Journal of Surgical Oncology 42 (9), S152, 2016 | | 2016 |
| 2054 Clinical outcomes of adolescent and young adult patients (AYAp) vs mature adult patients (MATp) with colorectal cancer (CRC), a multi-institutional retrospective review YS Rho, M Gilabert, I Barrera, N Coleman, M Greally, R McDermott, ... European Journal of Cancer 51, S346-S347, 2015 | | 2015 |
| P-286 Clinical and laboratory factors in young colorectal cancer patients with liver-only disease treated with upfront CAPOX and Bevacizumab combination–Single institution … V Petrova, Z Mihaylova, V Megdanova, D Petkova Annals of Oncology 26, iv84, 2015 | | 2015 |
| Continuum of care in advanced non-small lung cancer patients (ANSCLC). Z Mihaylova, VG Megdanova, V Petrova, D Petkova-Nelova, A Fakirova, ... Journal of Clinical Oncology 33 (15_suppl), e19132-e19132, 2015 | | 2015 |
| Pancreatic neuroendocrine tumors (pNET) in adolescent and young adult (AYA) population: A multi-institutional study of characteristics and outcomes. M Gilabert, Y Rho, VG Megdanova, ZM Milanova, JL Raoul, P Viens, ... Journal of Clinical Oncology 33 (15_suppl), e15173-e15173, 2015 | | 2015 |
| 2354 Is pancreatic adenocarcinoma more aggressive in adolescents and young adults? A multi-institute retrospective study M Gilabert, YS Rho, V Megdanova, Z Mihaylova, S Rahal, P Viens, ... European Journal of Cancer 3 (51), S453, 2015 | | 2015 |
